Potential savings without compromising the quality of care

Keyphrases

• Adherence to Guidelines 50%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 50%
• Antidiabetic Agents 50%
• Antidiabetic Drugs 100%
• Blood Pressure 100%
• Cholesterol 100%
• Diabetes 100%
• Dispensed Prescription 50%
• Drug Treatment Outcomes 50%
• Ecological Design 50%
• First-line Drugs 50%
• Guideline Adherence 100%
• Hemoglobin A1c (HbA1c) 100%
• Hypercholesterolemia 100%
• Hypertension 100%
• Lipid-lowering Agents 50%
• Lipid-lowering Drugs 50%
• Logistic Regression 50%
• Marker Data 50%
• Medical Records 50%
• Outcome Markers 50%
• Patient Outcomes 50%
• Performance Practice 50%
• Potential Savings 100%
• Prescription Records 50%
• Primary Care 50%
• Primary Healthcare Centers 50%
• Quality of Care 100%
• Rational Drug Use 50%
• Registered Population 50%
• Renin-angiotensin 50%
• Simvastatin 50%
• Statins 50%
• Surrogate Marker 50%
• Surrogate Outcomes 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Angiotensin 33%
• Antidiabetic Agent 100%
• Antihypertensive 66%
• Antilipemic Agent 66%
• Dipeptidyl Carboxypeptidase Inhibitor 33%
• Disease Marker 33%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 33%
• Hypercholesterolemia 66%
• Renin 33%
• Simvastatin 33%